Zentiva, pharmaceutical company, interior, production, manufacture, Ibalgin, ibuprofen

Zentiva, pharmaceutical company, interior, production, manufacture, Ibalgin, ibuprofen

Manufacturing facility of Zentiva pharmaceutical company is pictured in Prague, Czech Republic on Monday, Mar. 23, 2009. Zentiva, an international pharmaceutical company focused on selling, manufacturing and developing generic pharmaceutical products, employs more then 6000 people in Czech Republic, Slovakia, Romania and Turkey. Zentiva saw its net profit fall by 32.9 percent to 948 millions of Czech crowns last year, while its net sales rose by 10.2 percent to 18.4 billions of Czech crowns, the firm said in a press release today. (CTK Photo/Josef Horazny)

  • Product Code
  • ILEA000254785
  • Registered date
  • 2009/3/23 00:00:00
  • Credit
  • CTK / Kyodo News Images
  • Media source
  • CTK
  • Media size
  • 3133 × 3200 pixel
  • Resolution
  • 300 dpi
  • Deployment size
  • 1.49(MB)*
  • Special instruction
  • SLOVAKIA OUT, CZECH REPUBLIC OUT
    **The text may be generated by an automatic translation system**

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Sellier & Bellot ammunition maker, ammo, bullet, bullets, cartridge, cartridges

    Sellier & Bellot ammunition maker, ammo, bullet, bullets, cartridge, cartridges

    Sellier & Bellot ammunition maker saw its sales fall to Kc4.3bn in 2018 from Kc4.5bn in 2017, which was mainly due to exchange rates, but it expects mild growth for 2019, company representatives said on October 3, 2019, in Vlasim, Czech Republic. Sellier & Bellot, employing nearly 1,600 people, said it was heading for another increase in production volume in the future. Last year's turnover was affected by the fact that the company exports 90 percent of its production and a major part is in US dollars, Sellier & Bellot head Radek Musil said. The company is preparing for the European Union lead ammunition ban but it worries about negative impacts on its clients, as alternatives will be more expensive and of worse quality, Musil said. On the photo is seen a small exhibition of products in production plant in Vlasim. (CTK Photo/Josef Vostarek)
      Sellier & Bellot ammunition maker, ammo, bullet, bullets, cartridge, cartridges

      Sellier & Bellot ammunition maker, ammo, bullet, bullets, cartridge, cartridges

      Sellier & Bellot ammunition maker saw its sales fall to Kc4.3bn in 2018 from Kc4.5bn in 2017, which was mainly due to exchange rates, but it expects mild growth for 2019, company representatives said on October 3, 2019, in Vlasim, Czech Republic. Sellier & Bellot, employing nearly 1,600 people, said it was heading for another increase in production volume in the future. Last year's turnover was affected by the fact that the company exports 90 percent of its production and a major part is in US dollars, Sellier & Bellot head Radek Musil said. The company is preparing for the European Union lead ammunition ban but it worries about negative impacts on its clients, as alternatives will be more expensive and of worse quality, Musil said. On the photo is seen a part of production plant in Vlasim. On the photo is seen one of products of the company. (CTK Photo/Josef Vostarek)
        Sellier & Bellot ammunition maker

        Sellier & Bellot ammunition maker

        Sellier & Bellot ammunition maker saw its sales fall to Kc4.3bn in 2018 from Kc4.5bn in 2017, which was mainly due to exchange rates, but it expects mild growth for 2019, company representatives said on October 3, 2019, in Vlasim, Czech Republic. Sellier & Bellot, employing nearly 1,600 people, said it was heading for another increase in production volume in the future. Last year's turnover was affected by the fact that the company exports 90 percent of its production and a major part is in US dollars, Sellier & Bellot head Radek Musil said. The company is preparing for the European Union lead ammunition ban but it worries about negative impacts on its clients, as alternatives will be more expensive and of worse quality, Musil said. On the photo is seen a part of production plant in Vlasim. (CTK Photo/Josef Vostarek)
          Sellier & Bellot ammunition maker, CEO Radek Musil

          Sellier & Bellot ammunition maker, CEO Radek Musil

          Sellier & Bellot ammunition maker saw its sales fall to Kc4.3bn in 2018 from Kc4.5bn in 2017, which was mainly due to exchange rates, but it expects mild growth for 2019, company representatives said on October 3, 2019, in Vlasim, Czech Republic. Sellier & Bellot, employing nearly 1,600 people, said it was heading for another increase in production volume in the future. Last year's turnover was affected by the fact that the company exports 90 percent of its production and a major part is in US dollars, Sellier & Bellot head Radek Musil said. The company is preparing for the European Union lead ammunition ban but it worries about negative impacts on its clients, as alternatives will be more expensive and of worse quality, Musil said. On the photo poses CEO of the company Radek Musil. (CTK Photo/Josef Vostarek)
            Sellier & Bellot ammunition maker

            Sellier & Bellot ammunition maker

            Sellier & Bellot ammunition maker saw its sales fall to Kc4.3bn in 2018 from Kc4.5bn in 2017, which was mainly due to exchange rates, but it expects mild growth for 2019, company representatives said on October 3, 2019, in Vlasim, Czech Republic. Sellier & Bellot, employing nearly 1,600 people, said it was heading for another increase in production volume in the future. Last year's turnover was affected by the fact that the company exports 90 percent of its production and a major part is in US dollars, Sellier & Bellot head Radek Musil said. The company is preparing for the European Union lead ammunition ban but it worries about negative impacts on its clients, as alternatives will be more expensive and of worse quality, Musil said. On the photo is seen a part of production plant in Vlasim. (CTK Photo/Josef Vostarek)
              Sellier & Bellot ammunition maker

              Sellier & Bellot ammunition maker

              Sellier & Bellot ammunition maker saw its sales fall to Kc4.3bn in 2018 from Kc4.5bn in 2017, which was mainly due to exchange rates, but it expects mild growth for 2019, company representatives said on October 3, 2019, in Vlasim, Czech Republic. Sellier & Bellot, employing nearly 1,600 people, said it was heading for another increase in production volume in the future. Last year's turnover was affected by the fact that the company exports 90 percent of its production and a major part is in US dollars, Sellier & Bellot head Radek Musil said. The company is preparing for the European Union lead ammunition ban but it worries about negative impacts on its clients, as alternatives will be more expensive and of worse quality, Musil said. On the photo is seen a part of production plant in Vlasim. (CTK Photo/Josef Vostarek)
                HARTMUT JENNER, MILADA SKUTILOVA, JOHANNES KARCHER

                HARTMUT JENNER, MILADA SKUTILOVA, JOHANNES KARCHER

                Karcher CR, a company specialising in the development, production and sales of cleaning devices, saw its sales rise by 15 percent to Kc592.3m last year, its net profit growing by 11.5 percent to Kc39.9m, company executive Milada Skutilova, centre, told in Prague, Czech Republic, November 29, 2018. Karcher CR today opened its new seat in Modletice near Prague, the construction of which has cost Kc140m. From left HARTMUT JENNER, MILADA SKUTILOVA, JOHANNES KARCHER. (CTK Photo/Vit Simanek)
                  Zentiva, pharmaceutical company, interior, production, manufacture

                  Zentiva, pharmaceutical company, interior, production, manufacture

                  Manufacturing facility of Zentiva pharmaceutical company, Prague, Czech Republic on Monday, Mar. 23, 2009. Zentiva, an international pharmaceutical company focused on selling, manufacturing and developing generic pharmaceutical products, employs more then 6000 people in Czech Republic, Slovakia, Romania and Turkey. (CTK Photo/Josef Horazny)